Reports Q3 revenue $16.7B, consensus $16.5B. Dr. Albert Bourla, Chairman and CEO of Pfizer (PFE): “I am proud of Pfizer’s leadership as the first in our industry to reach an agreement with the U.S. Government, which we believe provides greater clarity for our business. Additionally, our recent strategic actions have strengthened opportunities to advance innovation that could address significant medical needs in high growth markets, helping us deliver value for patients and shareholders.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- These Are the Stocks Reporting Earnings Today – November 4, 2025
- Closing Bell Movers: Palantir down 3% after earnings
- Is Pfizer (PFE) a Good Stock to Buy before Earnings?
- Notable companies reporting before tomorrow’s open
- AstraZeneca (AZN) Wins Vote to List Directly in New York — Here’s What It Means for Investors